{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:05:21Z","timestamp":1762898721281},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T00:00:00Z","timestamp":1304553600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This paper describes the development of a web-based tool, GenDrux, which extracts and presents (over the Internet) information related to the disease-gene-drug nexus. This information is archived from the relevant biomedical literature using automated methods. GenDrux is designed to alleviate the difficulties of manually processing the vast biomedical literature to identify disease-gene-drug relationships. GenDrux will evolve with the literature without additional algorithmic modifications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>GenDrux, a pilot system, is developed in the domain of breast cancer and can be accessed at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.microarray.uab.edu\/drug_gene.pl\" ext-link-type=\"uri\">http:\/\/www.microarray.uab.edu\/drug_gene.pl<\/jats:ext-link>. GenDrux can be queried based on drug, gene and\/or disease name. From over 8,000 relevant abstracts from the biomedical literature related to breast cancer, we have archived a corpus of more than 4,000 articles that depict gene expression-drug activity relationships for breast cancer and related cancers. The archiving process has been automated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The successful development, implementation, and evaluation of this and similar systems when created may provide clinicians with a tool for literature management, clinical decision making, thus setting the platform for personalized therapy in the future.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6947-11-28","type":"journal-article","created":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T18:18:40Z","timestamp":1304619520000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["GenDrux: A biomedical literature search system to identify gene expression-based drug sensitivity in breast cancer"],"prefix":"10.1186","volume":"11","author":[{"given":"Chiquito","family":"Crasto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dajie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feliciano","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Forero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,5]]},"reference":[{"key":"407_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/1471-2105-8-275","volume":"8","author":"L Xu","year":"2007","unstructured":"Xu L, Geman D, Winslow RL: Large-scale integration of cancer microarray data identifies a robust common cancer signature. BMC bioinformatics. 2007, 8: 275-10.1186\/1471-2105-8-275.","journal-title":"BMC bioinformatics"},{"issue":"4","key":"407_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/sj.tpj.6500487","volume":"8","author":"JT Cross","year":"2008","unstructured":"Cross JT, Poole EM, Ulrich CM: A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia. The pharmacogenomics journal. 2008, 8 (4): 237-47. 10.1038\/sj.tpj.6500487.","journal-title":"The pharmacogenomics journal"},{"issue":"4","key":"407_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S1084-8592(99)80013-7","volume":"4","author":"MW Linder","year":"1999","unstructured":"Linder MW, Valdes R: Pharmacogenetics in the practice of laboratory medicine. Mol Diagn. 1999, 4 (4): 365-79. 10.1016\/S1084-8592(99)80013-7.","journal-title":"Mol Diagn"},{"issue":"5","key":"407_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/FPC.0b013e32833d1011","volume":"21","author":"DSS Berlin","year":"2011","unstructured":"Berlin DSS, Klein K, Altman TE, R B: PharmGKB summary: cytochrome P450, family 2, subfamily J, polypeptide 2: CYP2J2. Pharmacogenet Genomics. 2011, 21 (5): 308-11. 10.1097\/FPC.0b013e32833d1011.","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"407_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/nar\/30.1.163","volume":"30","author":"MO Hewett","year":"2002","unstructured":"Hewett MO, Rubin DE, Easton DL, Stuart KL, Altman JM, Klein RB, T E: PharmGKB: the Pharmacogenetics Knowledge Base. Nucleic Acids Res. 2002, 30 (1): 163-5. 10.1093\/nar\/30.1.163.","journal-title":"Nucleic Acids Res"},{"key":"407_CR6","first-page":"652","volume-title":"Pac Symp Biocomput","author":"R Leaman","year":"2008","unstructured":"Leaman R, Gonzalez G: BANNER: an executable survey of advances in biomedical named entity recognition. Pac Symp Biocomput. 2008, 652-63."},{"issue":"14","key":"407_CR7","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1093\/bioinformatics\/bti475","volume":"21","author":"B Settles","year":"2005","unstructured":"Settles B: ABNER: an open source tool for automatically tagging genes, proteins and other entity names in text. Bioinformatics. 2005, 21 (14): 3191-2. 10.1093\/bioinformatics\/bti475.","journal-title":"Bioinformatics"},{"issue":"1","key":"407_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1593\/neo.07859","volume":"10","author":"JY Yu","year":"2008","unstructured":"Yu JY, Cordero Jindan, Johnson Kevin, Ghosh Michael, Rae Debashis, Chinnaiyan James, Lippman Arul, Marc E: A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Neoplasia (New York, N Y). 2008, 10 (1): 79-88.","journal-title":"Neoplasia (New York, N Y)"},{"issue":"3","key":"407_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s12272-001-1163-z","volume":"31","author":"JWK Yang","year":"2008","unstructured":"Yang JWK, Kim Mi Ra, Kim Hyung Gyoon, Jeong Sang Kyum, Kang Hye Gwang, Wook Keon: Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells. Archives of pharmacal research. 2008, 31 (3): 350-6. 10.1007\/s12272-001-1163-z.","journal-title":"Archives of pharmacal research"},{"issue":"2","key":"407_CR10","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/bcr1989","volume":"10","author":"GS von Minckwitz","year":"2008","unstructured":"von Minckwitz GS, Raab HP, Loibl G, Blohmer S, Eidtmann JU, Hilfrich H, Merkle J, Jackisch E, Costa CSD, Caputo A, Kaufmann M: Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. Breast Cancer Res. 2008, 10 (2): R30-10.1186\/bcr1989.","journal-title":"Breast Cancer Res"},{"key":"407_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2407-8-97","volume":"8","author":"LW Wang","year":"2008","unstructured":"Wang LW, Qian Jia, Yin Xiaoping, Zhao Haitao, Yu Yang, Wang Lixia, Liu Tingting, Baorui : ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and\/or docetaxel. BMC cancer. 2008, 8: 97-10.1186\/1471-2407-8-97.","journal-title":"BMC cancer"},{"issue":"7","key":"407_CR12","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.freeradbiomed.2008.01.009","volume":"44","author":"SG Vibet","year":"2008","unstructured":"Vibet SG, Bougnoux C, Steghens P, Gore JP, Maheo JK: Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response. Free Radic Biol Med. 2008, 44 (7): 1483-91. 10.1016\/j.freeradbiomed.2008.01.009.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"407_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10549-007-9676-7","volume":"109","author":"AA Urruticoechea","year":"2008","unstructured":"Urruticoechea AA, Sole H, Capella X, Martin G, Dowsett LA, Germa-Lluch M, J R: Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer. Breast Cancer Res Treat. 2008, 109 (3): 463-70. 10.1007\/s10549-007-9676-7.","journal-title":"Breast Cancer Res Treat"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-11-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6947-11-28\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-11-28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-11-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T14:19:53Z","timestamp":1630505993000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/1472-6947-11-28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,5]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1186\/1472-6947-11-28","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,5]]},"assertion":[{"value":"28 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"28"}}